Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Amgen and Allergan close on Avastin biosimilar filing

Amgen and Allergan close on Avastin biosimilar filing the year, fractionally behind breast cancer drug Herceptin (trastuzumab). ... Meanwhile, biosimilars of other mAbs - including Herceptin, Humira, Amgen's arthritis drug Enbrel (etanercept) and Novartis/Roche's eye therapy Lucentis (ranibizumab) - have

First Merck/Samsung biosimilar cleared in South Korea

First Merck/Samsung biosimilar cleared in South Korea s breast cancer therapy Herceptin (trastuzumab) in late-stage clinical development.

Pfizer starts Ibrance trials in early breast cancer

Pfizer starts Ibrance trials in early breast cancer HER2 receptor targeted by drugs such as Roche's Herceptin (trastuzumab).

European approval for Roche’s next-gen breast cancer drug

European approval for Roche’s next-gen breast cancer drug Roche's new oncology drug Perjeta (pertuzumab) has been approved by the European Commission to treat certain breast cancer patients when used in combination with its ageing drug Herceptin (trastuzumab). ... However, the high cost of Perjeta plus

Roche pharma sales strong for first half of 2015

Roche pharma sales strong for first half of 2015 Its ageing breast cancer drug Herceptin (trastuzumab) and multi-cancer licensed Avastin (bevacizumab) were both a close second, recording identical sales of CHF3.26bn, up 11% and 9% respectively. ... big-selling cancer drugs - most notably Herceptin -

[ Previous 5 results ] 11 12 13 14 15 16 17 18 19 20 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics